Celgene Corp.

Pharmaceuticals
United States
Executive 1Mr. Robert J. Hugin, Chairman; ; Chief Executive Officer | Chairman; ; Chief Executive Officer
Executive 2Mr. Mark J. Alles, President; Chief Operating Officer | Senior Vice President; Chief Financial Officer
Earnings Per Share Growth (%)41.84%
Cost of Goods Sold (US$ Millions)$386
Current Liabilities (US$ Millions)$2,112
Total Assets (US$ Millions)$9,713
Long Term Debt (Millions)$6,266
Return on Equity35.78%
Revenue (US$ Millions)$7,670
Total Company Assets$17,340
Revenue Growth (%)18.12%
Net Income (US$ Millions)$2,000
Earnings Per Share (US$)$2.39
Total Equity (US$ Millions)$6,525
Profit Margin (%)26.07%
Debt To Equity Ratio (%)0.96%
Inventories (Millions)$393